Literature DB >> 3324124

Effects of recombinant plasmid size on cellular processes in Escherichia coli.

U E Cheah1, W A Weigand, B C Stark.   

Abstract

The effects of recombinant plasmid size on cell growth and viability, plasmid copy number, and synthesis of plasmid-encoded protein were investigated in Escherichia coli using plasmid pUC8 and four recombinant derivatives containing inserts of Drosophila melanogaster DNA of 1.7-6.0 kb. Growth in log phase was unaffected by plasmid size, but as plasmid size increased, maximum cell density decreased and, with the largest plasmid, cell death was accelerated after the stationary phase was reached. There was also a correlation between increasing plasmid size and decreased viability at high ampicillin concentrations, resistance to which is conferred by the plasmids. These effects were shown not to be due to transcription or translation of Drosophila sequences carried on the recombinant plasmids. Cells harboring the largest plasmid, pBS5 (8.7 kb), fared poorly in competition with plasmid-free cells in mixed cultures, compared with cells harboring pUC8 (2.7 kb). In addition, pBS5 was harbored at significantly fewer copies per cell than pUC8 at all phases of growth and supported much less production of the plasmid-encoded protein, beta-lactamase, than did pUC8. The results suggest that recombinant plasmid size may be an important parameter in the optimization of large-scale production of plasmid-encoded proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3324124     DOI: 10.1016/0147-619x(87)90040-0

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  17 in total

1.  Selection and characterization of alpha-amylase-overproducing recombinant Escherichia coli containing the bacterial hemoglobin gene.

Authors:  S C Liu; B Ogretmen; Y Y Chuang; B C Stark
Journal:  Appl Microbiol Biotechnol       Date:  1992-11       Impact factor: 4.813

2.  Plasmid macro-evolution: selection of deletions during adaptation in a nutrient-limited environment.

Authors:  R I Modi; C M Wilke; R F Rosenzweig; J Adams
Journal:  Genetica       Date:  1991       Impact factor: 1.082

3.  Fitness consequences of genetically engineered herbicide and antibiotic resistance in Arabidopsis thaliana.

Authors:  C B Purrington; J Bergelson
Journal:  Genetics       Date:  1997-03       Impact factor: 4.562

4.  Recombinant E. coli expressing Vitreoscilla haemoglobin prefers aerobic metabolism under microaerobic conditions: a proteome-level study.

Authors:  Bini Ramachandran; Kanak Lata Dikshit; Kuppamuthu Dharmalingam
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

5.  Kinetic and nuclear magnetic resonance studies of xylose metabolism by recombinant Zymomonas mobilis ZM4(pZB5).

Authors:  I S Kim; K D Barrow; P L Rogers
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

Review 6.  Bacterial gene transfer by natural genetic transformation in the environment.

Authors:  M G Lorenz; W Wackernagel
Journal:  Microbiol Rev       Date:  1994-09

7.  A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Authors:  James E Galen; Jin Yuan Wang; Jose A Carrasco; Scott A Lloyd; Gabriela Mellado-Sanchez; Jovita Diaz-McNair; Olga Franco; Amanda D Buskirk; James P Nataro; Marcela F Pasetti
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

Review 8.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

Review 9.  Replication of plasmids in gram-negative bacteria.

Authors:  U Kües; U Stahl
Journal:  Microbiol Rev       Date:  1989-12

10.  Metabolite profiling uncovers plasmid-induced cobalt limitation under methylotrophic growth conditions.

Authors:  Patrick Kiefer; Markus Buchhaupt; Philipp Christen; Björn Kaup; Jens Schrader; Julia A Vorholt
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.